These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26892346)

  • 21. TRPC6 - a new podocyte gene involved in focal segmental glomerulosclerosis.
    Kriz W
    Trends Mol Med; 2005 Dec; 11(12):527-30. PubMed ID: 16290061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gq signaling causes glomerular injury by activating TRPC6.
    Wang L; Jirka G; Rosenberg PB; Buckley AF; Gomez JA; Fields TA; Winn MP; Spurney RF
    J Clin Invest; 2015 May; 125(5):1913-26. PubMed ID: 25844902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription.
    Schlöndorff J; Del Camino D; Carrasquillo R; Lacey V; Pollak MR
    Am J Physiol Cell Physiol; 2009 Mar; 296(3):C558-69. PubMed ID: 19129465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis.
    Santín S; Ars E; Rossetti S; Salido E; Silva I; García-Maset R; Giménez I; Ruíz P; Mendizábal S; Luciano Nieto J; Peña A; Camacho JA; Fraga G; Cobo MA; Bernis C; Ortiz A; de Pablos AL; Sánchez-Moreno A; Pintos G; Mirapeix E; Fernández-Llama P; Ballarín J; Torra R; ; Zamora I; López-Hellin J; Madrid A; Ventura C; Vilalta R; Espinosa L; García C; Melgosa M; Navarro M; Giménez A; Cots JV; Alexandra S; Caramelo C; Egido J; San José MD; de la Cerda F; Sala P; Raspall F; Vila A; Daza AM; Vázquez M; Ecija JL; Espinosa M; Justa ML; Poveda R; Aparicio C; Rosell J; Muley R; Montenegro J; González D; Hidalgo E; de Frutos DB; Trillo E; Gracia S; de los Ríos FJ
    Nephrol Dial Transplant; 2009 Oct; 24(10):3089-96. PubMed ID: 19458060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRPC6 gene variants in Czech adult patients with focal segmental glomerulosclerosis and minimal change disease.
    Obeidová L; Reiterová J; Lněnička P; Štekrová J; Šafránková H; Kohoutová M; Tesař V
    Folia Biol (Praha); 2012; 58(4):173-6. PubMed ID: 22980509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function.
    Reiser J; Polu KR; Möller CC; Kenlan P; Altintas MM; Wei C; Faul C; Herbert S; Villegas I; Avila-Casado C; McGee M; Sugimoto H; Brown D; Kalluri R; Mundel P; Smith PL; Clapham DE; Pollak MR
    Nat Genet; 2005 Jul; 37(7):739-44. PubMed ID: 15924139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRPC6 Mutational Analysis in Iranian Children With Focal Segmental Glomerulosclerosis.
    Gheissari A; Meamar R; Kheirollahi M; Rouigari M; Dehbashi M; Dehghani L; Abedini A
    Iran J Kidney Dis; 2018 Nov; 12(6):341-349. PubMed ID: 30595563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryo-EM structure of the cytoplasmic domain of murine transient receptor potential cation channel subfamily C member 6 (TRPC6).
    Azumaya CM; Sierra-Valdez F; Cordero-Morales JF; Nakagawa T
    J Biol Chem; 2018 Jun; 293(26):10381-10391. PubMed ID: 29752403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury.
    Yu M; Hu J; Ju T; Wang R; Wang M; Gao C; Xia Z
    Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):284-288. PubMed ID: 38814201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRPC6 gene variants in Turkish children with steroid-resistant nephrotic syndrome.
    Mir S; Yavascan O; Berdeli A; Sozeri B
    Nephrol Dial Transplant; 2012 Jan; 27(1):205-9. PubMed ID: 21511817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic Interactions Between TRPC6 and NPHS1 Variants Affect Posttransplant Risk of Recurrent Focal Segmental Glomerulosclerosis.
    Sun ZJ; Ng KH; Liao P; Zhang Y; Ng JL; Liu ID; Tan PH; Chong SS; Chan YH; Liu J; Davila S; Heng CK; Jordan SC; Soong TW; Yap HK
    Am J Transplant; 2015 Dec; 15(12):3229-38. PubMed ID: 26147534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis.
    Barua M; Brown EJ; Charoonratana VT; Genovese G; Sun H; Pollak MR
    Kidney Int; 2013 Feb; 83(2):316-22. PubMed ID: 23014460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological inhibition of focal segmental glomerulosclerosis-related, gain of function mutants of TRPC6 channels by semi-synthetic derivatives of larixol.
    Urban N; Neuser S; Hentschel A; Köhling S; Rademann J; Schaefer M
    Br J Pharmacol; 2017 Nov; 174(22):4099-4122. PubMed ID: 28800680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
    Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
    J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis.
    Winn MP; Conlon PJ; Lynn KL; Farrington MK; Creazzo T; Hawkins AF; Daskalakis N; Kwan SY; Ebersviller S; Burchette JL; Pericak-Vance MA; Howell DN; Vance JM; Rosenberg PB
    Science; 2005 Jun; 308(5729):1801-4. PubMed ID: 15879175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mutation in TRPC6 channels abolishes their activation by hypoosmotic stretch but does not affect activation by diacylglycerol or G protein signaling cascades.
    Wilson C; Dryer SE
    Am J Physiol Renal Physiol; 2014 May; 306(9):F1018-25. PubMed ID: 24598806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
    Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
    Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collapsing Glomerulopathy in a Patient with a TRPC6 Mutation Presenting as Rapidly Progressive Glomerulonephritis: A Case Report and Review of the Literature.
    Gokce I; Kaya M; Cicek N; Guven S; Ercetin Y; Yildiz N; Kaya H; Alpay H
    Saudi J Kidney Dis Transpl; 2023 May; 34(3):254-258. PubMed ID: 38231721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SNF8, a member of the ESCRT-II complex, interacts with TRPC6 and enhances its channel activity.
    Carrasquillo R; Tian D; Krishna S; Pollak MR; Greka A; Schlöndorff J
    BMC Cell Biol; 2012 Nov; 13():33. PubMed ID: 23171048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gain-of-function, focal segmental glomerulosclerosis Trpc6 mutation minimally affects susceptibility to renal injury in several mouse models.
    Brown BJ; Boekell KL; Stotter BR; Talbot BE; Schlondorff JS
    PLoS One; 2022; 17(8):e0272313. PubMed ID: 35913909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.